Summary : Intelsius (A DGP Company) are global manufacturers and suppliers of UN compliant Temperature Control Packaging Solutions. Their core business consists of cold chain and sample transport packaging solutions for the Pharmaceutical; Biotechnology; Clinical Trial; Medical & Veterinary Research sectors. They provide global supply locally through their manufacturing and distribution centres which are located in the UK, USA, Malaysia, Holland and Russia.
Phone: +44 1904 607 390 Fax: +44 1904 607 391 Address: 1 Harrier Court, Airfield Business Park, Elvington, York, YO41 4AU, United Kingdom
Categories: Passive Thermal System, Rigid / Bricks Gel Packs, Flexible Bags Gel Packs, Molded Insulated Containers, Panels Insulated Containers, Chemical Temperature Monitor, Mechanical Temperature Monitor
New Products or Services
This company does not have any available information on new products or services at this time.
White Papers
No White Papers Found
Press Release
Intelsius Expands International Manufacturing and Distribution Infrastructure in South Korea 03-27-2012
"SEOUL, South Korea, March 27, 2012 /PRNewswire via COMTEX/ -- Intelsius, a global designer, manufacturer and distributor of temperature-controlled and regulatory-compliant packaging solutions, announced a partnership with BioCore in South Korea. In line with the company's international growth strategy, the partnership with BioCore aligns the growing global presence of Intelsius and its core strategy of offering products globally with local supply." Click here for full press release.
Company News
Intelsius Launches New Patient Safety Products 02-01-2012
"Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces the launch of its new Thermotrek range of products.
Thermotrek systems are a range of insulated, patient carry cases designed for movement of temperature sensitive medications either being tested in clinical trials or for approved and marketed medicines used by patients. The success or failure of clinical trials often depends on crucial passive climate controls to ensure the efficacy of medicines. In commercially available temperature sensitive medicines the systems ensure the patient’s investment in treatment is not wasted while ensuring efficacy of the medicine. Thermotrek systems are qualified to maintain contents at the required temperature for up to 24 hours and designed to give many months of use." Click here for more information.